The Israeli Ministry of Health (MOH) approved a Phase I/II trial of Enlivex Therapeutics Ltd.’s (NASDAQ:ENLV) proprietary immunotherapy drug-candidate AllocetraTM. AllocetraTM is a cell therapy that uses healthy
Why Taboola Shares Are Trading Higher By Around 53%? Here Are 53 Stocks Moving In Monday’s Mid-Day Session
November 28, 2:01 PM
Gainers Taboola.com Ltd. (NASDAQ: TBLA) shares gained 52.5% to $2.8050 after the company announced it entered into a 30-year exclusive commercial agreement with Yahoo.
November 28, 1:41 PM
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
November 28, 7:08 AM
According to a U.K. trial, Eliquis (apixaban), widely prescribed for COVID-19, did not help patients recovering from moderate and severe COVID. The drug used after discharge from the hospital does not lessen the chances for COVID-19 patients of readmission or improve survival.
November 27, 10:28 AM
Bristol Myers Squibb Data At ASH 2022 Highlight Innovative Therapeutic Platforms Across A Range Of Blood Diseases
November 21, 7:59 AM
New data from our multiple myeloma portfolio across targets and molecular approaches show significant progress toward our goal of transforming the treatment paradigm and improving outcomes for patients Multiple first
November 18, 3:42 PM
Credit Suisse has initiated coverage on Bristol-Myers Squibb Co (NYSE:BMY) with a Neutral rating and a price target of $78. The analysts…